Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01866865 · ClinicalTrials.gov registry record
Adaptation to Living With a BRCA1/2 Mutation
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 142
- Enrollment target
NCT01866865 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 142 participants.
The verdict
NCT01866865 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 142 participants
- Enrollment target
Study Summary
Background: \- Women who have a BRCA1/2 gene mutation have a very high risk of developing breast or ovarian cancer. They are also at increased risk of other developing other cancers. Male carriers are at increased risk for breast, prostate and other cancers. Testing for this mutation and living with this increased risk can be a source of stress for both people with the mutation and their partners. Researchers want to look at how well people adapt to living with this type of cancer risk over time. Objectives: \- To see how women with the BRCA1/2 gene mutation and their partners adapt to the stress of long-term cancer risk. Eligibility: \- Women at least 18 years of age who have a BRCA1/2 mutation, and their male or female partners. Design: * This study involves a one-time self-administered questionnaire. Participants will be recruited from local and national hereditary cancer support groups and cancer centers. * There are two versions of the survey. One is for the woman with the BRCA1/2 gene mutation. The other is for her partner. * The survey will ask about risk perception, cancer worry, risk-related stress, and coping and adaptation methods. * Treatment will not be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2013-05-02 |
| Est. Completion | 2014-02-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01866865
The ClinicalTrials.gov registry entry for NCT01866865 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01866865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01866865 about?
NCT01866865 is a clinical study titled "Adaptation to Living With a BRCA1/2 Mutation". Background: \- Women who have a BRCA1/2 gene mutation have a very high risk of developing breast or ovarian cancer. They are also at increased risk of other developing other cancers. Male carriers are at increased risk for breast, prostate and other cancers. Testing for this mutation and living wit...
What is the current status of trial NCT01866865?
This trial is currently completed. The enrollment target is 142 participants. The study started on 2013-05-02. Estimated completion is 2014-02-20.
Who is sponsoring clinical trial NCT01866865?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.